SORT BY Relevancy
Allison Risha, RN, BSN, OCN, a nursing program coordinator from the Levine Cancer Institute in Charlotte, North Carolina, joins Mike and Joyce to talk about the current state of clinical trials for genitourinary cancers. Ms. Risha has worked in many aspects of cancer treatment, and is currently a planner and organizer of programs for staff members and patients. Please join us, and bring your own questions about clinical trials, what they offer beyond standard treatments, and what to think abo
In 2013 Pfizer launched the Pfizer Blue Button Project, a first-of-it’s-kind initiative enabling patients who have participated in clinical trials the opportunity to download their individual clinical data. Using the Blue Button standard launched by the White House, patients will be empowered to use the data to improve their overall health and wellness, from sharing with healthcare providers to powering clinical risk assessments. In this show, our host Craig Lipset,
How a patient experiences a clinical trial is changing. Access, ease, efficiencey, safety and better quality data collection are the target goals. This episode features some of the emerging technologies together with a discussion on the opportunities and challenges to include patient access, recruitment and retention. Predictions for 2014 are shared by our guests. Host: Craig H. Lipset, MBA Head of Clinical Innovation, Worldwide Research and Development, Pfizer Inc. Guests: Tomasz Sabl
Dr. Philip McCarthy will be discussing how he and his team uses their own clinical data to determine treatment options, in conjunction with clinical trial data. Dr. McCarthy is the Director of the Blood & Marrow Transplant Program at Roswell Park Cancer Institute, and a Professor of Oncology. Dr. McCarthy has been a BMT physician and hematologist and oncologist since finishing fellowship training in 1989.
He has been the BMT Director at the RPCI since 1997. Hes a member of the Cancer and Leukemia Group B, Cooperative Clinical Trials Group, the Center for Institutional Research on Blood and Marrow Transplantation (CIRBMT) , as well as a member of the editorial board of the two BMT Journals. He has been a clinical investigator in oncology particularly in BMT for more than 20 years. He served as a chair or co-chair of many clinical trials and is a member of the protocol team for the ongoing BMT Clinical Trials Network study, and we will get into those studies as we go. Dr. McCarthy is a member of ASH and ASCO, and his research interests are devoted to developing new auto and allo treatments for hematological disorders including myeloma that will lead to improved patient outcomes and decreased toxicity.
Panelists: Gary Petersen, Jack Aiello, Cynthia Chmielewski and Lizzy Smith
CLICK HERE to REGISTER (or) Mail firstname.lastname@example.org
Our guest on Monday, February 10, 2014 is David Fuehrer. Dave is a two-time testicular cancer survivor and President of CureLauncher, a company he cofounded. Prior to doing so, Dave spent 10 years developing new products across North America, China and Europe for Pfizer, General Electric, Dow and many others. Dave will share his mission to solve the clinical trial enrollment problem that currently exists in the United States. His company and website connects people to lifesaving med
Join guests Kerri Weingard, ANP, COO, Verified Clinical Trials and Susan Salgado, PhD, Founder, Hospitality Quotient as they identify the barriers and limitations in engaging patients in clinical trials. What we can do about it through communication and service? Hosted by Valerie Bowling, Executive Director, the Conference Forum, this episode addresses one of the hottest topics at the Patients as Partners event scheduled for March 3-4, 2014 in Philadelphia. For more information, visit www.theco
This episode provides a recap on what's happening with mobile/sensors in clinical trials especially as they affect patients. Host: Craig Lipset, Head of Clinical Innovation, R&D, Pfizer, Inc. Guests: Tim Davis, CEO & Co-Founder, Exco InTouch Abbe Steel, Vice President of Patient & Physician Services, UBC
Topic: Plastic Surgeon Reports on his Clinical Results with ML830 Cold Laser Guest: Dr. Man, MD Host: Mike Barbour Take a 90 Day Test Drive: www.ml830wholesale.com Prices starting under $3000 1-888-658-3094, ext 101
in Self Help
WHOLISM...the act and condition of being whole, complete,Authentic! How do we maintain our health and sanity when serious prognoses invade our sense of comfort and security?
How does Cancer develop and what are the conditions of its Opportunist invasions?uch
Can food be of any consequence to such dire circumstances?
Doctors want us to avoid giving our bodies Nutritional advantages when in their care...they say they will "interfere" with the medical model...is that valid? Is it more likely that we further challenge the body's ability to rally and heal if we drain it of its own resources and functions?
How much do Allopathic drugs and proceedures destroy of the body...and of the pathogen?
Can food have ANY bearing on all this?
These are questions Michael Pellegrino, Clinical Nutritionist will again answer as best he can.
Michael's passion is to become fully knowledgeable about cancer and how nutrition plays its part in a cancer's survival or clearing.
With Great Love,
Rev. Irene Windhorse
Eli Lilly and Quintiles entered into a co-investment partnership to develop a new solution using computer-assisted designs that emphasize the improvement of scientific and operational outcomes of clinical trials. The results were shared at the DPharm 2013 event and project leaders from both companies will talk to our host Craig Lipset on how this formation is doing a year later. Also joining Craig is Jeff Lee, CEO, Omniscience to discuss featured news and trends in clinical trial innovation an
JuLee Hawkfeather is a gifted Energy Reader/Healer Psychic Medium. She is the recipient of a BA in English and Drama, and studied film at University of California at Santa Barbara and writing at Yale University. As a student of Native American shamans and teachers; and extensive studies with the re-known author of “Life After Life” Dr. Raymond Moody she was awarded a Certification of Ordination in Paranormal Studies; additionally JuLee holds a Doctorate of Divinity, which culminated from her studies with the esteemed Dr. Moody.In 1993, Ju Lee was awarded ordination completing her studies with internationally recognized psychic Claudia Archibald. She credits Ms. Archibald for recognizing her gifts and encouraging her Spiritual work. A typical reading begins with JuLee tapping into her natural clairvoyant, clairsentient, and clairaudient abilities and reading the client’s energy field. JuLee often uses the skill of remote viewing during a telephone reading.When needed, during a reading a client is often given a spontaneous Soul Retrieval or a Shamanic Energy Healing.As a medium, JuLee contacts the “other side” bringing details from the deceased. JuLee’s always amazed and grateful for “Spirit” allowing her “go between” status.A Medium reading creates touching and emotional healings for both the client and their loved one.As a clinical hypnotherapist, JuLee’s Past Life Regression sessions heal http://www.juleehawkfeather.com.....Or email at http://email@example.com.